1. Identification of fibronectin type III domain containing 3B as a potential prognostic and therapeutic target for pancreatic cancer: a preliminary analysis
   Yizhi Wang et al, 2024, European Journal of Medical Research CrossRef
2. 6:2 Cl-PFESA, a proposed safe alternative for PFOS, diminishes the gemcitabine effectiveness in the treatment of pancreatic cancer
   Jiawei Hong et al, 2024, Journal of Hazardous Materials CrossRef
3. Nicotine promotes epithelial to mesenchymal transition and gemcitabine resistance via hENT1/RRM1 signalling in pancreatic cancer and chemosensitizing effects of Embelin-a naturally occurring benzoquinone
   null Prashanth N et al, 2024, Science of The Total Environment CrossRef